Polypeptide growth factors activate common signal transduction pathways, ye
t they can induce transcription of different target genes. The mechanisms t
hat control this specificity are not completely understood. Recently, we ha
ve described a fibroblast growth factor (FGF)-inducible response element, F
IRE, on the syndecan-1 gene. In NIH 3T3 cells, the FiRE is activated by FGF
-2 but not by several other growth factors, such as platelet-derived growth
factor or epidermal growth factor, suggesting that FGF-2 activates signali
ng pathways that diverge from pathways activated by other growth factors. I
n this paper, we report that the activation of FIRE by FGF-2 requires prote
in kinase A (PKA) in NIH 3T3 cells. The PKA-specific inhibitor H-89 (N-[2-(
p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide) blocked the FGF-2-in
duced activation of FIRE, the transcription of the syndecan-1 gene, and cel
l proliferation. Also, expression of a dominant-negative form of PKA inhibi
ted the FC F-2-induced FIRE activation and the transcription of the syndeca
n-1 gene. The binding of activator protein-1 transcription-factor complexes
, required for the activation of FIRE, was blocked by inhibition of PKA act
ivity before FGF-2 treatment. In accordance with the growth factor specific
ity of FiRE, the activity of PKA was stimulated by FGF-2 but not by platele
t-derived growth factor or epidermal growth factor. Furthermore, a portion
of the PKA catalytic subunit pool was translocated to the nucleus by FGF-2.
Noticeably, the total cellular cAMP concentration was not affected by FGF-
2 stimulus. We propose that the FGF-2-selective transcriptional activation
through FIRE is caused by the ability of FGF-2 to control PKA activity.